GB9413073D0 - Helicobacter pylori vaccines/therapeutic compositions - Google Patents

Helicobacter pylori vaccines/therapeutic compositions

Info

Publication number
GB9413073D0
GB9413073D0 GB9413073A GB9413073A GB9413073D0 GB 9413073 D0 GB9413073 D0 GB 9413073D0 GB 9413073 A GB9413073 A GB 9413073A GB 9413073 A GB9413073 A GB 9413073A GB 9413073 D0 GB9413073 D0 GB 9413073D0
Authority
GB
United Kingdom
Prior art keywords
helicobacter pylori
therapeutic compositions
pylori vaccines
vaccines
therapeutic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
GB9413073A
Other versions
GB2290710B (en
GB2290710A (en
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Reckitt Benckiser Healthcare UK Ltd
Original Assignee
Reckitt and Colman Products Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Reckitt and Colman Products Ltd filed Critical Reckitt and Colman Products Ltd
Priority to GB9413073A priority Critical patent/GB2290710B/en
Publication of GB9413073D0 publication Critical patent/GB9413073D0/en
Priority to DE19523554A priority patent/DE19523554A1/en
Priority to IT95TO000545A priority patent/IT1276453B1/en
Publication of GB2290710A publication Critical patent/GB2290710A/en
Application granted granted Critical
Publication of GB2290710B publication Critical patent/GB2290710B/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/205—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Campylobacter (G)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/52—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from bacteria or Archaea
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • General Engineering & Computer Science (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
GB9413073A 1994-06-29 1994-06-29 Protease from helicobacter pylori for use in vaccines/therapeutic compositions Expired - Fee Related GB2290710B (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
GB9413073A GB2290710B (en) 1994-06-29 1994-06-29 Protease from helicobacter pylori for use in vaccines/therapeutic compositions
DE19523554A DE19523554A1 (en) 1994-06-29 1995-06-28 Helicobacter pylori vaccines and therapeutic compositions
IT95TO000545A IT1276453B1 (en) 1994-06-29 1995-06-29 HELYCOBACTER PYLORI VACCINE/THERAPEUTIC COMPOSITIONS, THEIR PREPARATION AND USE.

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB9413073A GB2290710B (en) 1994-06-29 1994-06-29 Protease from helicobacter pylori for use in vaccines/therapeutic compositions

Publications (3)

Publication Number Publication Date
GB9413073D0 true GB9413073D0 (en) 1994-08-17
GB2290710A GB2290710A (en) 1996-01-10
GB2290710B GB2290710B (en) 1998-03-25

Family

ID=10757523

Family Applications (1)

Application Number Title Priority Date Filing Date
GB9413073A Expired - Fee Related GB2290710B (en) 1994-06-29 1994-06-29 Protease from helicobacter pylori for use in vaccines/therapeutic compositions

Country Status (3)

Country Link
DE (1) DE19523554A1 (en)
GB (1) GB2290710B (en)
IT (1) IT1276453B1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1997039764A1 (en) * 1996-04-23 1997-10-30 Toray Industries, Inc. Antipylori agent

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2637612B1 (en) * 1988-10-06 1993-09-10 Pasteur Institut NUCLEOTIDE SEQUENCES ENCODING A PROTEIN WITH UREASIC ACTIVITY
AU3728293A (en) * 1992-02-26 1993-09-13 Vanderbilt University Purified vacuolating toxin from (helicobacter) pylori and methods to use same
AU3630093A (en) * 1992-03-02 1993-10-05 Biocine S.P.A. Helicobacter pylori proteins useful for vaccines and diagnostics

Also Published As

Publication number Publication date
DE19523554A1 (en) 1996-01-04
IT1276453B1 (en) 1997-10-31
ITTO950545A0 (en) 1995-06-29
ITTO950545A1 (en) 1996-12-29
GB2290710B (en) 1998-03-25
GB2290710A (en) 1996-01-10

Similar Documents

Publication Publication Date Title
HUP9901546A3 (en) Helicobacter pylori antigens and vaccine compositions
AP9400629A0 (en) Vaccine compositions
GB9408117D0 (en) Pharmaceutical formulations
ZA978868B (en) Vaccine composition
GB9404248D0 (en) Pharmaceutical formulations
EP0754057A4 (en) COMPOSITIONS AND METHODS FOR VACCINES COMPRISING -g(a)-GALACTOSYL EPITOPES
PL331424A1 (en) Antipaludian vaccine composition
ZA979984B (en) Vaccine composition
IL110035A0 (en) Homeopathic formulations
GB9401787D0 (en) Vaccine compositions
AU1698699A (en) (helicobacter pylori) vaccine formulations
GB9326425D0 (en) Vaccine compositions
GB9413073D0 (en) Helicobacter pylori vaccines/therapeutic compositions
HUP0003164A3 (en) Vaccine compositions comprising the helicobacter pylori flge polypeptide
GB9614618D0 (en) Vaccine compositions
ZA957482B (en) Vaccine
GB9413050D0 (en) Helicobacter pylori carbonic anhydrase-like protein
AU8048698A (en) Vaccine compositions comprising the (helicobacter pylori) pfr polypeptide
GB9419661D0 (en) Mouse model for helicobacter pylori infection
GB9403417D0 (en) Vaccine compositions
GB9416097D0 (en) Vaccine compositions
GB9601739D0 (en) Vaccine Compositions
GB9425980D0 (en) Vaccine compositions
GB9419969D0 (en) Vaccine
GB9621991D0 (en) Rotavirus vaccine formulations

Legal Events

Date Code Title Description
732E Amendments to the register in respect of changes of name or changes affecting rights (sect. 32/1977)
PCNP Patent ceased through non-payment of renewal fee

Effective date: 20030629